Le Lézard
Classified in: Health, Business
Subject: CON

Groupe Sebbin Announces Agreement with Revitacare to Distribute Their Products in European Countries


BOISSY L'AILLERIE, France, October 12, 2017 /PRNewswire/ --

Groupe Sebbin announces that it has reached a broader agreement with Revitacare, following the success of their Spanish partnership.

     (Logo: http://mma.prnewswire.com/media/558818/Sebbin_Logo.jpg )
     (Logo: http://mma.prnewswire.com/media/582350/Revitacare_Logo.jpg )

Since 2008 Groupe Sebbin has been partnering with Revitacare in Spain. Today, the partnership will be extended to other European Countries including Germany, Switzerland, Netherlands, Belgium, Luxembourg.

This agreement will allow Sebbin to establish a firmer foot by reinforcing its strength into the aesthetic market and become a bigger player in the non-invasive product market with top products for face and hair by using its direct network in Europe of almost 50 sales representatives.

The products:

The launch of this cooperation is scheduled to start Q4 of 2017.

Diederik Van Goor, CEO of group Sebbin states: 

"This partnership is a win-win agreement for both Sebbin and Revitacare and a great opportunity for Sebbin to accelerate its European expansion and offer noninvasive products to the aesthetic industry. We, at Sebbin, are very excited about this agreement"

Martine Buzon, Chairwoman of Revitacare states: 

"This agreement could not come at a better time for Revitacare, it consolidates the successful investment in the current partnership and will help to boost our sales covering additional countries where Revitacare was not present. We are then very pleased to extend our partnership with Sebbin and I am expecting to be a success for everyone involved."

About Sebbin

Groupe Sebbin is a global medical device company headquartered in France established for more than 30 years. It creates, develops, manufactures and markets high quality implants, expanders and other solutions for aesthetic and reconstructive surgery.

All products are manufactured with the upmost care and attention at its cutting-edge facility close to Paris. Strict quality control over 100% of their silicone implants ensures optimum safety for the patient.

patient safety is thE number one priority at all times.

Group Sebbin uses only long-term implantable medical grade silicone registered by the FDA (Food & Drugs Administration). The application of ISO 9001 and 13485 standards ensures full compliance with the requirements of European Directive 93/42. 

About Revitacare: 

REVITACARE is a French Laboratory specialized in cutting-edge research, development and manufacturing of anti-aging highly elaborated formulas. Thanks to its specific knowledge and expertise, REVITACARE has been recognized as a pioneer in delivering specific complex with ingredients combined with Hyaluronic acid. Their range is dedicated to medical aesthetic and cosmetology markets, to treat aging effects, aesthetic and various cosmetic concerns. Their products are distributed in over 40 countries thanks to a wide international distribution network.

REVITACARE was honored with several awards for their products including CYTOCARE as « Best Mesotherapy product » and HAIRCARE as "Best hair beauty product". These awards are the recognition of their high performance and represent their conviction to develop efficient and safe products. It scored REVITACARE as a key player in manufacturing of sophisticated formulas.

Since 2003, their focus is to develop innovative products to comply with the highest safety standards to meet practitioners and patients' expectations.

Contacts:

Groupe Sebbin
39-43 Parc d'Activités des Quatre Vents
95650 Boissy l'Aillerie - France
Tel : +331-3442-1328
Email : [email protected]
Website: www.sebbin.com

Revitacare
Héliparc, 6 rue saint Simon
95310 Saint-Ouen-l'Aumone
Tel : +33-130373145
Email : [email protected]
Website: www.revitacare.com


These press releases may also interest you

at 12:05
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...

at 12:02
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...

at 11:56
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....



News published on and distributed by: